E-LIB Suche - Ergebnisse für: Rackham, Mark

1

Optimization of a Series of RIPK2 PROTACs:

Miah, Afjal H. ; Smith, Ian E. D. ; Rackham, Mark...
Journal of Medicinal Chemistry. 64 (2021) 17 - p. 12978-13003 , 2021

Link: https://doi.org/10.1021/..

2

Extended pharmacodynamic responses observed upon PROTAC-med..:

Mares, Alina ; Miah, Afjal H. ; Smith, Ian E. D....
Communications Biology. 3 (2020) 1 - p. , 2020

Link: https://doi.org/10.1038/..

3

A caged E3 ligase ligand for PROTAC-mediated protein degrad..:

Kounde, Cyrille S. ; Shchepinova, Maria M. ; Saunders, Charlie N....
Chemical Communications. 56 (2020) 41 - p. 5532-5535 , 2020

Link: https://doi.org/10.1039/..

4

Discovery of high affinity inhibitors of Leishmania donovan..:

Rackham, Mark D. ; Yu, Zhiyong ; Brannigan, James A....
MedChemComm. 6 (2015) 10 - p. 1761-1766 , 2015

Link: https://doi.org/10.1039/..

5

Design and Synthesis of High Affinity Inhibitors of Plasmod..:

Rackham, Mark D. ; Brannigan, James A. ; Rangachari, Kaveri...
Journal of Medicinal Chemistry. 57 (2014) 6 - p. 2773-2788 , 2014

Link: https://doi.org/10.1021/..

6

N-Myristoyltransferase as a potential drug target in malari..:

TATE, EDWARD W. ; BELL, ANDREW S. ; RACKHAM, MARK D..
Parasitology. 141 (2013) 1 - p. 37-49 , 2013

Link: https://doi.org/10.1017/..

7

Discovery of Novel and Ligand-Efficient Inhibitors of Plasm..:

Rackham, Mark D. ; Brannigan, James A. ; Moss, David K....
Journal of Medicinal Chemistry. 56 (2012) 1 - p. 371-375 , 2012

Link: https://doi.org/10.1021/..

8

The medicinal chemistry of mitochondrial dysfunction: a cri..:

Lee, Maximillian Taro William ; Mahy, William ; Rackham, Mark David
RSC Medicinal Chemistry. 12 (2021) 8 - p. 1281-1311 , 2021

Link: https://doi.org/10.1039/..

9

Extended pharmacodynamic responses observed upon PROTAC-med..:

Mares, Alina ; Miah, Afjal H ; Smith, Ian E. D...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083851/. , 2020

Link: http://www.ncbi.nlm.nih...

10

Design and Synthesis of High Affinity Inhibitors of Plasmod..:

Rackham, Mark D ; Brannigan, James A ; Rangachari, Kaveri...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC. , 2014

Link: http://www.ncbi.nlm.nih...

11

Validation of N-myristoyltransferase as an antimalarial dru..:

Wright, Megan H ; Clough, Barbara ; Rackham, Mark D...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4739506/. , 2013

Link: http://www.ncbi.nlm.nih...

12

Discovery of Novel and Ligand-Efficient Inhibitors of Plasm..:

Rackham, Mark D ; Brannigan, James A ; Moss, David K...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601602. , 2012

Link: http://www.ncbi.nlm.nih...

13

The medicinal chemistry of mitochondrial dysfunction: a cri..:

Lee, Maximillian Taro William ; Mahy, William ; Rackham, Mark David
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372206/. , 2021

Link: http://www.ncbi.nlm.nih...

14

Optimization of a Series of RIPK2 PROTACs:

Afjal H. Miah (11332004) ; Ian E. D. Smith (10891097) ; Mark Rackham (11332007)...
https://figshare.com/articles/dataset/Optimization_of_a_Series_of_RIPK2_PROTACs/16441700. , 2021

Link: https://doi.org/10.1021/..

15

Optimization of a Series of RIPK2 PROTACs:

Afjal H. Miah (11332004) ; Ian E. D. Smith (10891097) ; Mark Rackham (11332007)...
https://figshare.com/articles/journal_contribution/Optimization_of_a_Series_of_RIPK2_PROTACs/16441697. , 2021

Link: https://doi.org/10.1021/..